← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 19, 2015Last known activity
Sep 19, 2020
Timeline
2010s
- Jun 1, 2014
Asana BioSciences— Founded
Drugs by trial phase (7 distinct, 12 trials)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Chronic Disease
- Colonic Neoplasms
- Colorectal Neoplasms
- Dermatitis
- Dermatitis, Atopic
- Eczema
- Leukemia
- Leukemia, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Peripheral
- Neoplasm Metastasis
- Neoplasms
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Primary Myelofibrosis
- Prostatic Neoplasms
- Pruritus
Recent trials (23)
- NCT04410224Study directorPhase 1Sep 19, 2020
- NCT04410224Lead sponsorPhase 1Sep 19, 2020
- NCT03798561Study directorPhase 1Jan 14, 2019
- NCT03798561Lead sponsorPhase 1Jan 14, 2019
- NCT03728504Study directorPhase 2Jan 3, 2019
- NCT03728504Lead sponsorPhase 2Jan 3, 2019
- NCT03654755Lead sponsorPhase 2Sep 30, 2018
- NCT03641573Study directorPhase 1Sep 30, 2018
- NCT03641573Lead sponsorPhase 1Sep 30, 2018
- NCT03654755Study directorPhase 2Sep 30, 2018
- NCT03531957Lead sponsorPhase 2Jul 5, 2018
- NCT03531957Study directorPhase 2Jul 5, 2018
- NCT03415126Lead sponsorPhase 1Jan 19, 2018
- NCT03415126Study directorPhase 1Jan 19, 2018
- NCT03139981Study directorPhase 1Apr 12, 2017
Details
- Founded
- Princeton, NJ, US Jun 1, 2014
- Last known activity
- Sep 19, 2020